Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)-Reference-Cited by-同舟云学术

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)

Published:2018-03-13 Issue:2 Volume:181 Page:215-228
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Smith Alexandra¹^ORCID,Roman Eve¹^ORCID,Appleton Simon¹,Howell Debra¹,Johnson Rod²,Burton Cathy²³,Patmore Russell⁴

Affiliation:

1. Epidemiology & Cancer Statistics Group; Department of Health Sciences; University of York; York UK

2. Department of Clinical Haematology; St James's University Hospital; Leeds UK

3. Haematological Malignancy Diagnostic Service; St James's University Hospital; Leeds UK

4. Queen's Centre for Oncology and Haematology; Hull and East Yorkshire Hospitals; Cottingham UK

Funder

Bloodwise

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15170/fullpdf

Reference46 articles.

1. Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry;Abrahamsson;Leukaemia & Lymphoma,2011

2. Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study;Abrahamsson;Blood,2014

3. A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors;Andersen;European Journal of Cancer,2002

4. Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?;Atilla;International Journal of Hematology,2017

5. Cancer Research UK Cancer Survival Group 2017 UK life tables [WWW Document] http://csg.lshtm.ac.uk/tools-analysis/uk-life-tables/(accessed

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions: Treatment Evolution of Mantle Cell Lymphoma: Navigating the Different Entities and Biological Heterogeneity of Mantle Cell Lymphoma in 2024;Clinical Lymphoma Myeloma and Leukemia;2024-08

2. Real-World Evidence of Relapsed/Refractory Mantle Cell Lymphoma Patients and Treatments: A Systematic Review;Journal of Blood Medicine;2024-05

3. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK’s Haematological Malignancy Research Network;Cancer Epidemiology;2024-02

4. Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study;Blood Cancer Journal;2023-11-13

5. Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline;British Journal of Haematology;2023-10-25